InsiderTrades

Form 4 for HCA HCA Healthcare

Accepted 2024-05-08 00:00:00 ET · period of report 2024-05-06 · accession 0001209191-24-005570 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2024-05-08 2024-05-06 HCA Cuffe Michael S. EVP, Chief Clinical Off S - Sale+OE $309.00 -1,600 34.1K -4% -$494.4K
D 2024-05-08 2024-05-07 HCA Cuffe Michael S. EVP, Chief Clinical Off M - OptEx $139.06 +18.7K 52.8K +55% +$2.59M
D 2024-05-08 2024-05-08 HCA Cuffe Michael S. EVP, Chief Clinical Off G - Gift $0.00 -4,500 35.9K -11% $0
D 2024-05-08 2024-05-07 HCA Cuffe Michael S. EVP, Chief Clinical Off F - Tax $314.45 -12.3K 40.4K -23% -$3.88M
D 2024-05-08 2024-05-07 HCA Cuffe Michael S. EVP, Chief Clinical Off M - OptEx $0.00 -18.7K 0 -100% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2024-05-06 S D 1,600 $309.00 34,123.97 D — — (F1) Includes 2,463.9692 shares acquired under the HCA Holdings, Inc. Employee Stock Purchase Plan.
2 Common Common Stock 2024-05-07 M A 18,660 $139.06 52,783.97 D — — (F1) Includes 2,463.9692 shares acquired under the HCA Holdings, Inc. Employee Stock Purchase Plan.
3 Common Common Stock 2024-05-08 G D 4,500 $0.00 35,934.97 D — — (F1) Includes 2,463.9692 shares acquired under the HCA Holdings, Inc. Employee Stock Purchase Plan.
4 Common Common Stock 2024-05-07 F D 12,349 $314.45 40,434.97 D — — (F1) Includes 2,463.9692 shares acquired under the HCA Holdings, Inc. Employee Stock Purchase Plan.
5 Derivative Stock Appreciation Right 2024-05-07 M D 18,660 $0.00 0 D $139.06 · — to 2029-01-30 18,660 Common Stock (F2) The stock appreciation rights vested in four equal annual installments beginning on January 30, 2020.